Lab Manager | Run Your Lab Like a Business

Avacta Group

Avacta Group

Avacta Group is focused on the development and commercialization of novel cancer therapies and diagnostics based on its proprietary Affimer® platform, a novel class of biotherapeutics that are designed to target and modulate the function of specific proteins implicated in various diseases.
Content from Avacta Group
Filter by